Herbas VPB

Print
EN | LT
Supplementary protection
LT - Bifenilsulfonamido endotelino ir angiotenzino II receptoriaus antagonistas, skirtas glomerulosklerozės ir IgA indukuotos nefropatijos gydymui
EN - A DIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR ANTAGONISTS TO TREATGLOMERULOSCLEROSIS
SPC
(11) Number of the document
(68) Number of the document 3222277
(21) Application number for Supplementary Protection Certificate PA 2024 527
(22) Date of filing the application 2024-10-08
(41) Date of publication of the application 2024-10-25
Date of publication of SPC
(24) Date of coming into effect of SPC
Applicant
(71) Ligand Pharmaceuticals Inc., 3911 Sorrento Valley Boulevard Suite 110, San Diego, CA 92121, US
Grantee
(73) Ligand Pharmaceuticals Inc., 3911 Sorrento Valley Boulevard Suite 110, San Diego, CA 92121, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/23/1788, 2024-04-19
Name of the product protected by the basic patent
(95) Sparsentanas arba farmaciniu požiūriu priimtina jo druska
Legal status
SPC application published
Last update date 2024-10-24